1. Home
  2. BZUN vs GBIO Comparison

BZUN vs GBIO Comparison

Compare BZUN & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.66

Market Cap

155.4M

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.70

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZUN
GBIO
Founded
2007
2016
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.4M
36.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BZUN
GBIO
Price
$2.66
$5.70
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$8.88
AVG Volume (30 Days)
172.4K
65.6K
Earning Date
11-25-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,372,022,139.00
$15,270,000.00
Revenue This Year
$6.28
N/A
Revenue Next Year
$4.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.08
N/A
52 Week Low
$2.12
$3.00
52 Week High
$4.88
$12.40

Technical Indicators

Market Signals
Indicator
BZUN
GBIO
Relative Strength Index (RSI) 40.30 60.89
Support Level $2.60 $5.40
Resistance Level $2.73 $5.69
Average True Range (ATR) 0.09 0.22
MACD 0.01 0.04
Stochastic Oscillator 33.15 87.72

Price Performance

Historical Comparison
BZUN
GBIO

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: